Recent News

• 09.15.2025 - Kyverna Therapeutics to Highlight Interim Phase 2 Data from KYV-101 KYSA-6 Study in Myasthenia Gravis at AANEM 2025
• 09.15.2025 - Kyverna Therapeutics to Highlight Interim Phase 2 Data from KYV-101 KYSA-6 Study in Myasthenia Gravis at AANEM 2025
• 09.09.2025 - H.C. Wainwright 27th Annual Global Investment Conference
• 09.09.2025 - H.C. Wainwright 27th Annual Global Investment Conference
• 09.08.2025 - Morgan Stanley 23rd Annual Global Healthcare Conference
• 09.08.2025 - Morgan Stanley 23rd Annual Global Healthcare Conference
• 09.08.2025 - Morgan Stanley 23rd Annual Global Healthcare Conference
• 09.08.2025 - Morgan Stanley 23rd Annual Global Healthcare Conference
• 09.08.2025 - September 8, 2025 11:00 AM EDT - September 10, 2025 : H.C. Wainwright 27th Annual Global Investment Conference
• 09.08.2025 - September 8, 2025 11:00 AM EDT - September 10, 2025 : H.C. Wainwright 27th Annual Global Investment Conference

Recent Filings